Paydirt
GC
Insider

G Bradley Cole

Director

G Bradley Cole (Director) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in Castle Biosciences, Inc. (CSTL). The largest single filing was $299K of KNSA (3,673 sh × $81.43, as filed), executed Jul 29.

Add to watchlist
Return, ttmiAverage return per filing, trailing twelve months
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
returns measure stock purchases only
Filings, ttm
2
0 buys · 2 sells
Median delay
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$434K
shares × price, as filed
Last traded
Jul 29
Filed Jul 31

Median ADV $36.2M across their filed names

Open performance
Volume by month
$299K$150K$0Oct 2024Apr 2025Oct 2025Apr 2026Mar 2026 · sells $135KJul 2026 · sells $299K
Buys $0 Sells $434K

Shares × price, as filed · by filing month · past 24 months

Sectors filed on
Healthcare 2 filings

Sector per market data · by filing · past 12 months

Most traded names
CSTL Castle Biosciences, Inc. CSTL · 0 buys · 1 sell 1 filing KNSA Kiniksa Pharmaceuticals International, plc KNSA · 0 buys · 1 sell 1 filing
Recent filings
KNSASALE Kiniksa Pharmaceuticals International, plc View filing → $299K
3,673 sh × $81.43
Exec Jul 29
Filed Jul 31 · 4:34 PM ET
CSTLSALE Castle Biosciences, Inc. View filing → $135K
4,748 sh × $28.44
Exec Mar 5
Filed Mar 9 · 5:30 PM ET